Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05165368 · ClinicalTrials.gov registry record · NA
Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy
A NA study of Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation), sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT05165368 is a NA study of Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation) that has completed, run by Loma Linda University. The registered enrollment target is 46 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05165368, a NA study of Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation), has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to compare the effectiveness of providing dietary education to complement Intraneural Facilitation® Therapy (INF® Therapy) (a physical therapy technique being evaluated that may help improve circulation) versus INF® Therapy only in adults with a type of neuropathy called distal symmetric polyneuropathy (DSPN).
Conditions Studied
Interventions
- OTHER Intraneural Facilitation® Therapy (INF® Therapy)
- OTHER INF® Therapy
Study Locations (1)
California
- Loma Linda University Health - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2025-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05165368
The ClinicalTrials.gov registry entry for NCT05165368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation) appearing as the primary indexed condition, and to 2 interventions - of which Intraneural Facilitation® Therapy (INF® Therapy) is the first listed.
NCT05165368 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05165368 about?
NCT05165368 is a clinical study titled "Effect of Gluten-Free Dietary Education and Intraneural Facilitation® Therapy on Quality of Life in People With Diabetic Neuropathy". The purpose of this research is to compare the effectiveness of providing dietary education to complement Intraneural Facilitation® Therapy (INF® Therapy) (a physical therapy technique being evaluated that may help improve circulation) versus INF® Therapy only in adults with a type of neuropathy cal...
What is the current status of trial NCT05165368?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2023-08-01. Estimated completion is 2025-05-20.
What conditions does trial NCT05165368 study?
This clinical trial studies the following conditions: Diabetic Neuropathy, Distal Symmetric Polyneuropathy (Manifestation).
What interventions are being tested in trial NCT05165368?
The interventions under investigation include: Intraneural Facilitation® Therapy (INF® Therapy) (OTHER), INF® Therapy (OTHER).
Who is sponsoring clinical trial NCT05165368?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05165368 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.